priors.science/reviews/ace-inhibitors-and-angiotensin-receptor-blockers

ACE Inhibitors and Angiotensin Receptor Blockers

The current evidence on 18 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty — how firmly the literature supports the claim as stated.

18claims tracked
204primary papers reviewed
4 May 2026latest evidence review
Weeklyre-scored against new papers
7 Established · 8 Likely · 2 Uncertain · 1 Doubtful  |  four-reviewer panel · PICO Framework
SignalClaimStandingEvidence certaintyCorpus
StableACE inhibitors and ARBs slow proteinuric chronic kidney diseaseRenalEstablished92%11
StableACE inhibitors and ARBs reduce diabetic nephropathyRenalEstablished92%16
StableACE inhibitors and ARBs reduce mortality in heart failure with reduced ejection fractionHfrefEstablished91%6
StableACE inhibitor angioedema higher in Black patientsSafetyEstablished88%10
StableDual blockade increases hyperkalemiaDualEstablished87%8
StableACE inhibitor-induced cough is frequentSafetyEstablished87%13
StableARBs have lower adverse drug reaction risk than ACE inhibitorsSafetyEstablished86%11
StableACE inhibitors and ARBs: similar cardiovascular protectionComparativeLikely78%14
StableACE inhibitors and ARBs reduce major adverse cardiovascular events in high cardiovascular riskCVLikely78%15
StableACE inhibitor and ARB withdrawal worsens heart failure outcomesHfrefLikely77%9
StableHyperkalemia limits ACE inhibitor and ARB use in chronic kidney diseaseRenalLikely77%20
StableCombined ACE inhibitor and ARB: no cardiovascular benefitDualLikely75%8
StableNo renal benefit from stopping ACE inhibitors and ARBsRenalLikely71%13
StableACE inhibitors and ARBs improve ejection fraction in dilated cardiomyopathyHfrefLikely69%9
StableACE inhibitors: worse cardiovascular outcomes in Black patientsCVLikely66%10
StableWomen benefit from lower ACE inhibitor and ARB dosesHfrefUncertain63%10
StableARBs versus ACE inhibitors: lower all-cause mortalityComparativeUncertain60%14
StableACE inhibitor angioedema onset is delayedSafetyDoubtful39%7
Standing — what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely65–84%Well supported, with some gaps or indirect evidence.
Uncertain40–64%Mixed or limited evidence. Genuinely open.
Doubtful15–39%Little support; the weight of evidence leans against it.
Refuted< 15%The evidence contradicts it — confidently false as stated.
Recent signal
strengthenedNew evidence raised the certainty since the last review.
weakenedNew evidence lowered the certainty since the last review.
newA claim added to the review recently.
StableNo recent change to the standing.
Standing, evidence certainty and corpus are always shown. The study behind each move, why it moved, and the sceptic’s challenge are delivered to subscribers.
Update your priors.Track this topic